Skip to content

Clinical trials

Active, not recruiting Lung Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Active, not recruiting Country / region: Canada Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20161
20171
20182
20194
20202
20213
20225
20234
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
AstraZeneca3
Novartis Pharmaceuticals3
Eli Lilly and Company2
NRG Oncology2
National Cancer Institute (NCI)2
Actuate Therapeutics Inc.1
Alliance for Clinical Trials in Oncology1
Amgen1
Canadian Cancer Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms29
Carcinoma, Non-Small-Cell Lung15
Breast Neoplasms5
Neoplasms4
Colonic Neoplasms3
Colorectal Neoplasms3
Head and Neck Neoplasms3
Lung Diseases3
Melanoma3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.